How to step back from over-treatment in DGBI care

In brain-gut symptom management, “doing more” can quietly turn into doing harm. Led by Dr. Kim Bretz, this session explores how evidence, bias, and misinformation shape current care pathways, and how a brain-gut-first, sequencing-based approach can improve outcomes without adding complexity.

What you’ll learn

‍• How bias and misinformation influence DGBI decision-making – and what to do when more treatment makes things worse
• Why sequence, not intensity, matters when comparing brain-gut therapy and dietary restriction
• How to recognize and interrupt the over-treatment cycle before restriction takes over
• Practical ways to integrate brain-gut-first care into your existing approach without overhauling your practice

‍Download the presentation slides

‍

Contents

Fax: 212-377-0271

Nerva’s data is securely managed in compliance with SOC-2 standards

*Disclaimer: Nerva is a self-guided app that may help people self-manage and live well with their diagnosed irritable bowel syndrome. Nerva has not been evaluated by the FDA, TGA, MHRA or similar regulatory bodies. Users are directed to not make any changes to their prescribed medication or other type of medical treatment without seeking professional medical advice. Some in-app coaching content may be generated by an AI system for educational and wellness purposes only and does not replace professional medical care, diagnosis, or treatment.